[1]卢雯平,李向英,李晓,等.益气活血解毒中药联合树突状细胞疫苗对荷瘤小鼠免疫抑制的调控[J].中国中医药信息杂志,2013,20(3):46-48,54.[doi:10.3969/j.issn.1005-5304.2013.03.018]
 LU Wen-ping,LI Xiang-ying,LI Xiao,et al.Regulation of the Combination of Traditional Chinese Medicine and Dentric Cell Vaccine on Immune Suppression of Mice Xenografts[J].zhongguo zhongyiyao xinxi zazhi,2013,20(3):46-48,54.[doi:10.3969/j.issn.1005-5304.2013.03.018]
点击复制

益气活血解毒中药联合树突状细胞疫苗对荷瘤小鼠免疫抑制的调控

参考文献/References:

[1] NCCN Guidelines Version 1.2012 Cervical Cancer[S]. https:// subscriptions.nccn.org/login.aspx?returnurl=ContinueToEvent.aspx.

[2] 汪治宇,王聪敏,李幸.树突状细胞的肿瘤个体化治疗[J].药品评价, 2012,9(18):20-25.

[3] Novitskiy SV, Ryzhov S, Zaynagetdinov R, et al. Adenosine receptors in regulation of dendritic cell differentiation and function[J]. Blood,2008,112(5):1822-1831.

[4] Vander Most RG, Currie AJ, Robinson BW, et al. Decoding coding dangerous death: How cytotoxic chemotherapy invokes inflammation, immunity or nothing at all[J]. Cell Death Differ,2008,15:13-20

[5] Friedrich MJ. Nobel prize honors immunity researchers[J]. JAMA, 2011,306(18):1966-1967.

[6] Hovden AO, Appel S. The first dendritic cell-based therapeutic cancer vaccine is approved by the FDA[J]. Scand J Immunol,2010, 72(6):554.

[7] Steinman RM, Banchereau J. Taking dendritic cells into medicine[J]. Nature,2007,449(7161):419-426.

[8] Avigan D, Rosenblatt J, Kufe D. Dendritic/Tumor fusion cells as cancer vaccines[J]. Semin Oncol,2012,39(3):287-295.

[9] Zloza A, Jagoda MC, Lyons GE, et al. CD8 co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β- mediated suppression[J]. Cancer Immunol Immunother,2011,60(2):291-297.

[10] 林洪生.中国百年百名名中医——余桂清[M].北京:中国中医药出版社,2003:214-227.

[11] 张锡纯.医学衷中参西录(上)[M].北京:人民卫生出版社,2006:45-47.

[12] 陈良良,梁华.中医药免疫调节治疗恶性肿瘤研究进展[J].中国中医药信息杂志,2004,11(9):839-841.

[13] 邱志济,朱建平,马璇卿.朱良春杂病廉验特色发挥[M].北京:中医古籍出版社,2004:85-87.

备注/Memo

基金项目:人事部留学人员科技活动项目(2012年度);河北省卫生厅重点课题(20110060)

更新日期/Last Update: